{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:52:14Z","timestamp":1779360734704,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ijrobp.2020.05.062","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:59:06Z","timestamp":1618448346000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors"],"prefix":"10.1016","volume":"110","author":[{"given":"Priscilla K.","family":"Stumpf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen D.","family":"Yorke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issam","family":"El Naqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle C.","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimm","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karyn A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.05.062_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7","article-title":"Metastases in carcinoma; analysis of 1000 autopsied cases","volume":"3","author":"Abrams","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/1097-0142(19900315)65:6<1318::AID-CNCR2820650611>3.0.CO;2-H","article-title":"Palliative radiotherapy for symptomatic adrenal metastases","volume":"65","author":"Soffen","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0936-6555(96)80087-2","article-title":"Palliation of symptomatic adrenal gland metastases by radiotherapy","volume":"8","author":"Short","year":"1996","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jjco\/hyi020","article-title":"Radiation therapy for adrenal gland metastases from hepatocellular carcinoma","volume":"35","author":"Zeng","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","article-title":"Stereotactic body radiotherapy for treatment of adrenal metastases","volume":"75","author":"Chawla","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.rpor.2015.05.009","article-title":"SBRT: A viable option for treating adrenal gland metastases","volume":"20","author":"Ippolito","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","article-title":"Stereotactic body radiotherapy in the treatment of adrenal metastases","volume":"36","author":"Ahmed","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/COC.0b013e31821f876a","article-title":"Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors","volume":"35","author":"Barney","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ijrobp.2010.11.060","article-title":"Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience","volume":"82","author":"Casamassima","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13566-012-0037-8","article-title":"Stereotactic body radiotherapy for adrenal metastases from lung cancer","author":"Guiou","year":"2012","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00066-011-2192-z","article-title":"Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer","volume":"187","author":"Holy","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.radonc.2008.03.013","article-title":"Real-time tumor-tracking radiotherapy for adrenal tumors","volume":"87","author":"Katoh","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7785\/tcrt.2012.500320","article-title":"Stereotactic body radiation therapy for curative treatment of adrenal metastases","volume":"12","author":"Rudra","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/0284186X.2011.652738","article-title":"Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: A retrospective analysis of 34 patients","volume":"51","author":"Scorsetti","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/fon.10.165","article-title":"Stereotactic body radiation therapy for adrenal metastases: A retrospective review of a noninvasive therapeutic strategy","volume":"7","author":"Torok","year":"2011","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/tj.5000222","article-title":"Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer","volume":"101","author":"Gamsiz","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fonc.2015.00185","article-title":"A retrospective review of cyberknife stereotactic body radiotherapy for adrenal tumors (primary and metastatic): Winthrop University Hospital Experience","volume":"5","author":"Desai","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib19","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.prro.2016.09.005","article-title":"Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity","volume":"7","author":"Chance","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib20","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.2147\/OTT.S107106","article-title":"Clinical study on the influence of motion and other factors on stereotactic radiotherapy in the treatment of adrenal gland tumor","volume":"9","author":"Wang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib21","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1259\/0007-1285-67-803-1096","article-title":"Ultrasound quantitation of respiratory organ motion in the upper abdomen","volume":"67","author":"Davies","year":"1994","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mrm.1910230118","article-title":"Respiratory kinematics of the upper abdominal organs: A quantitative study","volume":"23","author":"Korin","year":"1992","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib23","article-title":"Treating adrenal tumors in 26 patients with CyberKnife: A mono-institutional experience","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.prro.2011.06.014","article-title":"Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary","volume":"2","author":"Solberg","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib25","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4143\/crt.2016.057","article-title":"Minimally invasive stereotactical radio-ablation of adrenal metastases as an alternative to surgery","volume":"49","author":"Franzese","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/COC.0b013e3181dbb727","article-title":"Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer","volume":"34","author":"Oshiro","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","article-title":"Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: A systematic review and pooled analysis","volume":"26","author":"Tanvetyanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","article-title":"Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery?","volume":"81","author":"Onishi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib30","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09553009214552071","article-title":"Tumour and normal tissue responses to fractionated non-uniform dose delivery","volume":"62","author":"Kallman","year":"1992","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2012.10.006","article-title":"Bioeffect modeling and equieffective dose concepts in radiation oncology\u2014terminology, quantities and units","volume":"105","author":"Bentzen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib33","first-page":"119","article-title":"Approximate is better than \u2018exact\u2019 for interval estimation of binomial proportions","volume":"52","author":"Agresti AaC","year":"1998","journal-title":"Am Stat"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fonc.2019.00732","article-title":"Usefulness of stereotactic body radiation therapy for treatment of adrenal gland metastases","volume":"9","author":"Scouarnec","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13014-018-1152-5","article-title":"Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer","volume":"13","author":"Zhao","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.adro.2018.05.006","article-title":"Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity","volume":"3","author":"Toesca","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijrobp.2020.01.017","article-title":"Stereotactic body radiotherapy of adrenal metastases: A pooled meta-analysis and systematic review of 39 studies with 1006 patients","volume":"107","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib38","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ctrv.2014.04.001","article-title":"Surgical and ablative therapies for the management of adrenal \u2018oligometastases' - A systematic review","volume":"40","author":"Gunjur","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2020.05.062_bib39","unstructured":"NRG Oncology. NRG-BR001: A phase I study of stereotactic body radiotherapy (SBRT) for the treatment of multiple metastases. Available at: https:\/\/www.nrgoncology.org\/Clinical-Trials\/Protocol\/nrg-br001?filter=nrg-br001. Accessed March 2017."},{"key":"10.1016\/j.ijrobp.2020.05.062_bib40","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(99)00700-X","article-title":"Real-time tumour-tracking radiotherapy","volume":"353","author":"Shirato","year":"1999","journal-title":"Lancet"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620312438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620312438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:51:17Z","timestamp":1759744277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620312438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0360301620312438"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.05.062","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.05.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}